The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues

The interdisciplinary interim experts counsil on March 3, 2016 in Moscow have considered the EMPA-REG OUTCOME trial results and suggested a number of prorositions and remommendations on further empagliflozins cardiovascular effects investigation and its clinical application in patients with type 2 d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Sakharnyĭ diabet 2016-05, Vol.19 (2), p.182-185
1. Verfasser:	Editorial team Diabetes Mellitus
Format:	Artikel
Sprache:	eng
Schlagworte:	cardiovascular disease empa-reg outcome trial empaglflozin mortality type 2 diabetes mellitus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The interdisciplinary interim experts counsil on March 3, 2016 in Moscow have considered the EMPA-REG OUTCOME trial results and suggested a number of prorositions and remommendations on further empagliflozins cardiovascular effects investigation and its clinical application in patients with type 2 diabetes at high cardiovascular risk.
ISSN:	2072-0351 2072-0378
DOI:	10.14341/DM2004156-61